Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
McKinsey
Medtronic
Baxter
Merck

Last Updated: February 7, 2023

Patent: 10,059,771


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 10,059,771
Title:Methods for treating nasal polyposis by administering an IL-4R antagonist
Abstract: The present invention provides methods for treating nasal polyposis. The methods include administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody or antigen binding fragment thereof.
Inventor(s): Mannent; Leda (Paris, FR), Pirozzi; Gianluca (Bridgewater, NJ), Radin; Allen (Tarrytown, NY), Gandhi; Namita A. (Tarrytown, NY), Evans; Robert (Tarrytown, NY)
Assignee: SANOFI BIOTECHNOLOGY (Paris, FR) REGENERON PHARMACEUTICALS, INC. (Tarrytown, NY)
Application Number:14/310,419
Patent Claims:see list of patent claims

Details for Patent 10,059,771

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 03/28/2017 See Plans and Pricing 2034-05-07
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 10/19/2018 See Plans and Pricing 2034-05-07
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 06/18/2020 See Plans and Pricing 2034-05-07
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 06/14/2021 See Plans and Pricing 2034-05-07
Regeneron Pharmaceuticals, Inc. DUPIXENT dupilumab Injection 761055 10/20/2021 See Plans and Pricing 2034-05-07
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Medtronic
Colorcon
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.